Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Abstract

IFX seems to be initiated earlier and also in less severe cases during the course of BS uveitis than before. Despite the few numbers of patients and relatively short duration of follow-up, our results give a hint that this change has improved the outcome.